Synthesis and antiproliferative activity of pyrrolo[3,2-b]pyridine derivatives against melanoma

Authors
Kim, Hee JinJung, Myung-HoKim, HwanEl-Gamal, Mohammed I.Sim, Tae BoLee, So HaHong, Jun HeeHah, Jung-MiCho, Jung-HyuckChoi, Jung HoonYoo, Kyung HoOh, Chang-Hyun
Issue Date
2010-01-01
Publisher
Pergamon Press Ltd.
Citation
Bioorganic & Medicinal Chemistry Letters, v.20, no.1, pp.413 - 417
Abstract
Synthesis of a new series of diarylureas and amides having pyrrolo[3,2-b]pyridine scaffold is described. Their in vitro antiproliferative activity against human melanoma cell line A375 and HS 27 human fibroblast cell line was tested and the effect of substituents on the pyrrolo[3,2-b]pyridine was investigated. The newly synthesized compounds, except meta-substituted derivatives (Ij-k and Iv-w), generally showed superior or similar activity against A375 to Sorafenib. Among all of these derivatives, compounds Ir and It having 5-benzylamide substituted 4'-amide moieties showed the most potent antiproliferative activity against A375. (C) 2009 Published by Elsevier Ltd.
Keywords
REFRACTORY SOLID TUMORS; FACTOR RECEPTOR INHIBITOR; RAF KINASE; SUBSTITUTED UREAS; PHASE-I; BAY-43-9006; THERAPY; PHARMACOKINETICS; INTERLEUKIN-2; PATHWAY; REFRACTORY SOLID TUMORS; FACTOR RECEPTOR INHIBITOR; RAF KINASE; SUBSTITUTED UREAS; PHASE-I; BAY-43-9006; THERAPY; PHARMACOKINETICS; INTERLEUKIN-2; PATHWAY; Pyrrolo[3,2-b]pyridine; A375; HS 27; Antiproliferative activity; Melanoma
ISSN
0960-894X
URI
https://pubs.kist.re.kr/handle/201004/131793
DOI
10.1016/j.bmcl.2009.08.005
Appears in Collections:
KIST Article > 2010
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE